The background and significance of “Expert Consensus”
Introducing the Internet and artificial intelligence into clinical research and adopting digital and intelligent research methods are important trends in the development of clinical research in the future. In order to promote the application of intelligent clinical research in China, it is led by the Pharmaceutical Clinical Research Professional Committee of Shanghai Pharmaceutical Association, under the guidance of the drug regulatory department, and experts from industry associations, research units, sponsors and contract research organizations (CRO) Discuss together. After months of hard work and hard work, the manuscript was successfully completed and the “Expert Consensus on Intelligent Clinical Research” was successfully published, providing an important reference for the development of intelligent clinical research in my country.
Sponsored by the Shanghai Pharmaceutical Association, “Co-drawing the New Pattern of Intelligent Clinical Research-“Intelligent Clinical Research Expert Consensus” Network Release and Expert Interpretation Sharing Session” will be held in the afternoon of July 24, 2020, and people from Shanghai Pharmaceutical Association, Shanghai Drug Evaluation and Verification Center, Shanghai Biomedical Technology Industry Promotion Center, Huashan Hospital Affiliated to Fudan University, Shanghai Mental Health Center, and leaders and guests from Pfizer, Ai Kunwei, and Home Credit Witness the first online release of the “Expert Consensus on Intelligent Clinical Research”, and explain the practical significance and specific application practices of the consensus. How will the domestic clinical intelligence policy develop in the future? How to use intelligent new technology in research in compliance? Welcome everyone to sign up for the event.